Jim Cramer on Becton, Dickinson: “The Company Showed Excellent Execution Across the Board”
Key takeaways
- Cramer highlighted the company’s latest quarterly earnings result, as he said:
- This morning, we got a strong quarter from Becton, Dickinson and Company, which is one of the major medical supply and medical technology companies.
- Becton, Dickinson and Company (NYSE:BDX) sells a significant variety of medical supplies, diagnostic tools, and lab equipment used by healthcare professionals and researchers.
Jim Cramer on Becton, Dickinson: “The Company Showed Excellent Execution Across the Board” Syeda Seirut Javed Sun, May 10, 2026 at 1:36 AM GMT+7 1 min read BDX Becton, Dickinson and Company (NYSE:BDX) was one of the stocks featured in Jim Cramer’s Mad Money recap, as he discussed how the AI build-out could power the economy. Cramer highlighted the company’s latest quarterly earnings result, as he said:
This morning, we got a strong quarter from Becton, Dickinson and Company, which is one of the major medical supply and medical technology companies. After spending the last five years with some fine growth, Becton, Dickinson really shot the lights out with this one. Huge top and bottom line beat, management raising the full year earnings forecast, and that sent the stock up nearly 6% today on a not-so-great day for the market. The company showed excellent execution across the board. They’re getting a real boost from all sorts of technology that helps hospitals do more with fewer people.
Becton, Dickinson and Company (NYSE:BDX) sells a significant variety of medical supplies, diagnostic tools, and lab equipment used by healthcare professionals and researchers.